About Amgen Inc.
Amgen Inc. (AMGN) has been publicly traded since 1983, making it a 43-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Thousand Oaks, United States and employs approximately 31,500 people. With a market capitalization of $197 billion, AMGN is a large established company.
Key Statistics
- Current Price
- $369.27
- Market Cap
- $199.06B
- 52-Week High
- $391.29
- 52-Week Low
- $261.43
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +13.60% | $325.06 | $369.27 |
| 2025 | +29.67% | $250.69 | $325.06 |
| 2024 | -6.77% | $268.90 | $250.69 |
| 2023 | +13.46% | $236.99 | $268.90 |
| 2022 | +20.43% | $196.78 | $236.99 |
| 2021 | +0.87% | $195.08 | $196.78 |
| 2020 | -1.99% | $199.03 | $195.08 |
| 2019 | +27.60% | $155.98 | $199.03 |
| 2018 | +15.23% | $135.36 | $155.98 |
| 2017 | +22.27% | $110.71 | $135.36 |
| 2016 | -7.56% | $119.76 | $110.71 |
| 2015 | +3.96% | $115.20 | $119.76 |
| 2014 | +42.33% | $80.94 | $115.20 |
| 2013 | +34.80% | $60.04 | $80.94 |
| 2012 | +36.83% | $43.88 | $60.04 |
| 2011 | +18.17% | $37.13 | $43.88 |
| 2010 | -2.95% | $38.26 | $37.13 |
| 2009 | -2.04% | $39.06 | $38.26 |
| 2008 | +24.35% | $31.41 | $39.06 |
| 2007 | -32.02% | $46.20 | $31.41 |
| 2006 | -13.38% | $53.34 | $46.20 |
| 2005 | +22.93% | $43.39 | $53.34 |
| 2004 | +3.82% | $41.79 | $43.39 |
| 2003 | +27.82% | $32.70 | $41.79 |
| 2002 | -14.35% | $38.18 | $32.70 |
| 2001 | -11.73% | $43.25 | $38.18 |
| 2000 | +6.45% | $40.63 | $43.25 |
| 1999 | +129.77% | $17.68 | $40.63 |
| 1998 | +93.19% | $9.15 | $17.68 |
| 1997 | -0.46% | $9.19 | $9.15 |
| 1996 | -8.42% | $10.04 | $9.19 |
| 1995 | +101.27% | $4.99 | $10.04 |
| 1994 | +19.19% | $4.19 | $4.99 |
| 1993 | -29.91% | $5.97 | $4.19 |
| 1992 | -6.77% | $6.40 | $5.97 |
| 1991 | +265.06% | $1.75 | $6.40 |
| 1990 | +154.08% | $0.69 | $1.75 |
| 1989 | +45.19% | $0.48 | $0.69 |
| 1988 | +8.87% | $0.44 | $0.48 |
| 1987 | +40.91% | $0.31 | $0.44 |
| 1986 | +62.96% | $0.19 | $0.31 |
| 1985 | +170.00% | $0.07 | $0.19 |
| 1984 | -31.03% | $0.10 | $0.07 |
Valuation
AMGN currently trades at a trailing P/E ratio of 25.7, which is considered high relative to the broader market. The forward P/E of 15.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 22.8. The price-to-sales ratio is 5.4.
Dividends
Amgen Inc. pays a dividend to shareholders with a current yield of 2.75%. This translates to $10.08 per share annually. The payout ratio of 67% indicates moderate dividend coverage.
Risk & Volatility
AMGN has a beta of 0.42, indicating it is less volatile than the overall market. The stock's 52-week range is $261.43 to $391.29, and it currently trades near its 52-week high.
Analyst Ratings
Based on 29 analyst opinions, AMGN has a consensus "buy" rating. The average price target of $350.03 suggests 4.4% downside from current levels.
Frequently Asked Questions
What does Amgen Inc. do? ▼
Amgen Inc. is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Thousand Oaks, United States.
What sector is AMGN in? ▼
AMGN operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did AMGN go public? ▼
Amgen Inc. went public in 1983, making it a 43-year-old public company as of 2026.
How much would $1,000 invested in AMGN 5 years ago be worth today? ▼
A $1,000 investment in AMGN five years ago would be worth approximately $1,887 today, representing a 88.7% return.
Does AMGN pay dividends? ▼
Yes, Amgen Inc. pays a dividend with a current yield of 2.75%, which is $10.08 per share annually.
What is AMGN's market cap? ▼
Amgen Inc. has a market capitalization of $197 billion, classifying it as a large-cap company.
What is AMGN's P/E ratio? ▼
AMGN has a trailing P/E ratio of 25.7 and a forward P/E of 15.7, which measures how much investors are paying per dollar of earnings.
Is AMGN a buy, hold, or sell? ▼
Based on 29 opinions, AMGN has a consensus "buy" rating. The average price target is $350.03.
Last updated: 3/14/2026